SCHIMMEL PAUL 4
4 · aTYR PHARMA INC · Filed Apr 28, 2023
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
SCHIMMEL PAUL
Director
Transactions
- Exercise/Conversion
Common stock
2023-04-26+6,000→ 8,890 total - Exercise/Conversion
Restricted Stock Unit
2023-04-26−6,000→ 0 total→ Common Stock (6,000 underlying)
Holdings
- 113,023(indirect: See Footnote)
Common stock
- 679,143(indirect: See Footnote)
Common stock
Footnotes (5)
- [F1]Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
- [F2]RSUs convert into common stock on a one-for-one basis.
- [F3]These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.
- [F4]These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
- [F5]The RSUs fully vested one year from the grant date which was April 26, 2022.